Your browser doesn't support javascript.
loading
Immune checkpoint inhibitors versus second line chemotherapy for patients with lung cancer refractory to first line chemotherapy.
Lefebvre, C; Martin, E; Hendriks, L E L; Veillon, R; Puisset, F; Mezquita, L; Ferrara, R; Sabatier, M; Filleron, T; Dingemans, A-M C; Besse, B; Raherisson, C; Mazières, J.
Afiliación
  • Lefebvre C; Department of Pneumology, University Hospital of Bordeaux, 33604 Pessac, France.
  • Martin E; Biostatistics Unit, Institut Claudius Regaud, IUCT-O, Toulouse, France.
  • Hendriks LEL; Department of Pulmonology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, Netherlands.
  • Veillon R; Department of Pneumology, University Hospital of Bordeaux, 33604 Pessac, France.
  • Puisset F; Pharmacy department IUCT (Institut Universitaire du Cancer) Oncopole, Institut Claudius-Regaud, Toulouse, France.
  • Mezquita L; Institut d'Oncologie Thoracique, Institut Gustave Roussy, Villejuif, France.
  • Ferrara R; Institut d'Oncologie Thoracique, Institut Gustave Roussy, Villejuif, France.
  • Sabatier M; Pharmacy department IUCT (Institut Universitaire du Cancer) Oncopole, Institut Claudius-Regaud, Toulouse, France.
  • Filleron T; Biostatistics Unit, Institut Claudius Regaud, IUCT-O, Toulouse, France.
  • Dingemans AC; Department of Pulmonology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, Netherlands.
  • Besse B; Institut d'Oncologie Thoracique, Institut Gustave Roussy, Villejuif, France.
  • Raherisson C; Department of Pneumology, University Hospital of Bordeaux, 33604 Pessac, France.
  • Mazières J; Pulmonology Department, Toulouse University Hospital, Université Paul Sabatier, Toulouse, France. Electronic address: mazieres.j@chu-toulouse.fr.
Respir Med Res ; 78: 100788, 2020 Nov.
Article en En | MEDLINE | ID: mdl-32980653
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Resistencia a Antineoplásicos / Inhibidores de Puntos de Control Inmunológico / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Respir Med Res Año: 2020 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Resistencia a Antineoplásicos / Inhibidores de Puntos de Control Inmunológico / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Respir Med Res Año: 2020 Tipo del documento: Article País de afiliación: Francia